Mesoridazine

Mesoridazine is a phenothiazine substituted at position 2 (para to the S atom) by a methylsulfinyl group, and on the nitrogen by a 2-(1-methylpiperidin-2-yl)ethyl group. Among its listed roles, it functions as a dopaminergic antagonist and a first generation antipsychotic. It is a sulfoxide, a member of phenothiazines and a tertiary amino compound. A phenothiazine antipsychotic with effects similar to chlorpromazine. Mesoridazine is a Phenothiazine. Mesoridazine is only found in individuals that have used or taken this drug. It is a phenothiazine antipsychotic with effects similar to chlorpromazine. Based upon animal studies, mesoridazine, as with other phenothiazines, acts indirectly on reticular formation, whereby neuronal activity into reticular formation is reduced without affecting its intrinsic ability to activate the cerebral cortex. Additionally, the phenothiazines exhibit at least part of their activities through depression of hypothalamic centers. Neurochemically, the phenothiazines are thought to exert their effects by a central adrenergic blocking action. It is grouped under the following drug class(es): Phenothiazine derivatives. Its therapeutic use is listed as antipsychotics. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Lidanar and Thioridazine-2-sulfoxide. Its PubChem CID is 4078.

CAS No 5588-33-0
Molecular Formula C21H26N2OS2
Molecular Weight 386.6 g/mol
Synonyms 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine

Frequently Asked Questions